Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytisine as a Smoking Cessation Agent: Improving Adherence Through a Better Understanding of Pharmacokinetics and Dose Response

NCT02585024 is registered in ClinicalTrials.gov with University of Auckland, New Zealand as lead sponsor.

NCT NCT02585024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02585024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytisine as a Smoking Cessation Agent: Improving Adherence Through a Better Understanding of Pharmacokinetics and Dose Response
Lead sponsor
University of Auckland, New Zealand
Phase
Phase 1
Overall status
Terminated
Start date
February 29, 2016
Completion date
March 31, 2019
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation